Pablo Letelier

1.2k total citations
33 papers, 921 citations indexed

About

Pablo Letelier is a scholar working on Molecular Biology, Infectious Diseases and Cancer Research. According to data from OpenAlex, Pablo Letelier has authored 33 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Cancer Research. Recurrent topics in Pablo Letelier's work include COVID-19 Clinical Research Studies (6 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Pablo Letelier is often cited by papers focused on COVID-19 Clinical Research Studies (6 papers), Cancer-related molecular mechanisms research (6 papers) and MicroRNA in disease regulation (5 papers). Pablo Letelier collaborates with scholars based in Chile, United States and Brazil. Pablo Letelier's co-authors include Juan Carlos Roa, Ismael Riquelme, Pamela Leal, Óscar Tapia, Alejandra Sandoval, Priscilla Brebi, Jorge G. Farías, Patricia García, Elías Figueroa and Rodrigo L. Castillo and has published in prestigious journals such as Gastroenterology, International Journal of Molecular Sciences and Nutrients.

In The Last Decade

Pablo Letelier

28 papers receiving 910 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Letelier Chile 16 509 336 162 133 128 33 921
Xiaowei Hu China 17 432 0.8× 222 0.7× 98 0.6× 61 0.5× 90 0.7× 56 791
Yoshinori Kasahara Japan 17 484 1.0× 285 0.8× 166 1.0× 60 0.5× 62 0.5× 37 1.1k
Qing Lü China 18 414 0.8× 173 0.5× 81 0.5× 268 2.0× 82 0.6× 36 1.3k
Jun Cao China 17 385 0.8× 136 0.4× 131 0.8× 122 0.9× 52 0.4× 48 823
Jianlin Chen China 16 443 0.9× 163 0.5× 161 1.0× 272 2.0× 83 0.6× 69 1.1k
Lei Tian China 16 468 0.9× 216 0.6× 96 0.6× 146 1.1× 64 0.5× 55 866
Jianting Cai China 20 338 0.7× 238 0.7× 305 1.9× 228 1.7× 78 0.6× 62 1.0k
Cristian Loretelli Italy 20 570 1.1× 413 1.2× 190 1.2× 382 2.9× 223 1.7× 65 1.4k
Xiuzhen Duan United States 19 441 0.9× 147 0.4× 85 0.5× 142 1.1× 72 0.6× 35 982

Countries citing papers authored by Pablo Letelier

Since Specialization
Citations

This map shows the geographic impact of Pablo Letelier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Letelier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Letelier more than expected).

Fields of papers citing papers by Pablo Letelier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Letelier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Letelier. The network helps show where Pablo Letelier may publish in the future.

Co-authorship network of co-authors of Pablo Letelier

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Letelier. A scholar is included among the top collaborators of Pablo Letelier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Letelier. Pablo Letelier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Letelier, Pablo, et al.. (2024). Development of a Model for Predicting Mortality Among Patients Hospitalized with COVID-19 During Their Stay in a Clinical Centre. Journal of Clinical Medicine. 13(23). 7300–7300. 1 indexed citations
3.
Letelier, Pablo, et al.. (2024). Dynamic changes of hematological and hemostatic parameters in COVID-19 hospitalized patients: Potential role as severity biomarkers for the Chilean population. Journal of Medical Biochemistry. 43(4). 556–564. 2 indexed citations
4.
Martin, Andrés, et al.. (2023). Obesity Is Associated with Changes in Laboratory Biomarkers in Chilean Patients Hospitalized with COVID-19. Journal of Clinical Medicine. 12(10). 3392–3392. 1 indexed citations
5.
Letelier, Pablo, et al.. (2023). Reference intervals of biochemical parameters in Chilean adults. Journal of Medical Biochemistry. 43(1). 133–143.
7.
Belén, Lisandra Herrera, et al.. (2023). l-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review. Medical Oncology. 40(5). 150–150. 14 indexed citations
8.
Letelier, Pablo, et al.. (2023). MicroRNAs as Potential Biomarkers of Environmental Exposure to Polycyclic Aromatic Hydrocarbons and Their Link with Inflammation and Lung Cancer. International Journal of Molecular Sciences. 24(23). 16984–16984. 8 indexed citations
9.
Viscardi, Sharon, et al.. (2022). Obesity as a Risk Factor for Severe COVID-19 in Hospitalized Patients: Epidemiology and Potential Mechanisms. Healthcare. 10(10). 1838–1838. 8 indexed citations
10.
Letelier, Pablo, et al.. (2022). Long-term survive of Aliarcobacter butzleri in two models symbiotic interaction with Acanthamoeba castellanii. Archives of Microbiology. 204(10). 610–610. 1 indexed citations
11.
Letelier, Pablo, et al.. (2020). Role of biochemical markers in the monitoring of COVID-19 patients. Journal of Medical Biochemistry. 40(2). 115–128. 38 indexed citations
12.
Letelier, Pablo, et al.. (2020). Workflow optimization in a clinical laboratory using Lean management principles in the pre-analytical phase. Journal of Medical Biochemistry. 40(1). 26–32. 15 indexed citations
13.
Letelier, Pablo, et al.. (2019). Enriquecimiento injustificado por actos de competencia desleal: Continuidad y divergencia en el derecho privado. Iuris Dictio. 13–13. 1 indexed citations
14.
Buchegger, Kurt, Carmen Ili, Ismael Riquelme, et al.. (2016). Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line. Biological Research. 49(1). 5–5. 15 indexed citations
15.
Castro‐Sepúlveda, Mauricio, et al.. (2016). Prevalence of Dehydration Before Training Sessions, Friendly and Official Matches in Elite Female Soccer Players. Journal of Human Kinetics. 50(1). 79–84. 27 indexed citations
16.
Riquelme, Ismael, Óscar Tapia, Pamela Leal, et al.. (2015). miR-101-2, miR-125b-2 and miR-451a act as potential tumor suppressors in gastric cancer through regulation of the PI3K/AKT/mTOR pathway. Cellular Oncology. 39(1). 23–33. 105 indexed citations
17.
Tapia, Óscar, Ismael Riquelme, Pamela Leal, et al.. (2014). The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(1). 25–33. 160 indexed citations
18.
Riquelme, Ismael, Óscar Tapia, Alejandra Sandoval, et al.. (2014). Mo1659 The PI3K/AKT/mTOR Pathway in Gastric Cancer and Its Potential Relationship With Mir-125b, Mir-451 and Mir-101. Gastroenterology. 146(5). S–629. 1 indexed citations
19.
Letelier, Pablo, Patricia García, Pamela Leal, et al.. (2013). Immunohistochemical Expression of Vascular Endothelial Growth Factor A in Advanced Gallbladder Carcinoma. Applied immunohistochemistry & molecular morphology. 22(7). 530–536. 29 indexed citations
20.
Letelier, Pablo, Priscilla Brebi, Óscar Tapia, & Juan Carlos Roa. (2012). DNA promoter methylation as a diagnostic and therapeutic biomarker in gallbladder cancer. Clinical Epigenetics. 4(1). 11–11. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026